Based on the 24‑hour urine catecholamines and metanephrines, plasma catecholamines and free metanephrines, and normal TSH, CBC, and CMP, does the patient have a pheochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pheochromocytoma Diagnosis Assessment

Based on the biochemical results provided, this patient does NOT have a pheochromocytoma. The plasma free metanephrines—the most sensitive and specific test available—are completely normal, which effectively rules out the diagnosis 1, 2.

Algorithmic Interpretation of Results

Most Critical Test: Plasma Free Metanephrines (Normal = Excludes Diagnosis)

  • Plasma metanephrine: 45 (normal)
  • Plasma normetanephrine: 122 (normal)
  • Total plasma free metanephrines: 167 (normal)

This normal result has 97-100% sensitivity and effectively excludes pheochromocytoma 3, 2. The 2014 Endocrine Society guideline explicitly states that plasma free metanephrines are the superior screening test with up to 99% sensitivity 1, 2. When these values are normal, pheochromocytoma can be confidently ruled out 4.

Secondary Tests: 24-Hour Urine Studies

Urine fractionated metanephrines:

  • Metanephrine: 120
  • Normetanephrine: 260
  • Total: 380

Urine catecholamines:

  • Epinephrine: 4
  • Norepinephrine: 25
  • Total: 181

Without reference ranges provided, these appear to be within or only mildly elevated above normal limits. Critically, the 2020 Hypertension Canada guidelines specify that mild elevations (less than twofold the upper limit of normal) should be considered potential false positives 1.

Plasma Catecholamines (Less Reliable)

  • Epinephrine: 37
  • Norepinephrine: 391
  • Dopamine: 12
  • Total: 440

Plasma catecholamines have significantly lower sensitivity (85%) compared to metanephrines and yield false-negative results in 15% of cases 4. They are also more prone to false-positive results from stress, positioning, and acute illness 1.

Why This Patient Does NOT Have Pheochromocytoma

Evidence-Based Reasoning:

  1. Normal plasma free metanephrines have 100% negative predictive value 4. In the landmark NIH study of over 800 patients, no patient with pheochromocytoma had normal plasma concentrations of both normetanephrine and metanephrine 2, 4.

  2. The 2009 AACE guidelines state that plasma metanephrine levels exceeding 3-4 times normal are highly diagnostic 3. This patient's values are not elevated at all.

  3. Guidelines explicitly warn about false-positive results when only one abnormal test exists in a panel 1. This patient has normal plasma metanephrines (the gold standard) with potentially borderline urine studies.

  4. The 2023 CUA/AUA guideline recommends against routine pheochromocytoma screening in patients with unequivocal adenomas on CT 5, though we lack imaging data here.

Common Pitfalls to Avoid

False-Positive Considerations 1:

  • Interfering medications: Tricyclic antidepressants, decongestants, amphetamines, phenoxybenzamine
  • Incorrect patient preparation: Not supine for 30 minutes before plasma collection
  • Acute illness or hospitalization: Stress-induced catecholamine release
  • Incomplete urine collection: Verify with 24-hour creatinine (yours shows 1.13, which needs comparison to expected range)

When Plasma and Urine Results Diverge:

The evidence strongly favors plasma free metanephrines over urine studies. A 2003 Mayo Clinic study found that while urine tests had higher specificity (98% vs 85%), plasma metanephrines had superior sensitivity (97% vs 90%) 6. More importantly, the 2007 European guidelines state that when plasma free metanephrines are not available for routine diagnosis, urinary fractionated metanephrines remain the diagnostic test of choice—but plasma is superior when available 7.

What to Do Next

No further testing for pheochromocytoma is warranted. The normal plasma free metanephrines exclude this diagnosis with extremely high confidence 1, 2, 4.

If Clinical Suspicion Remains High:

  • Review medication list for interfering substances
  • Ensure plasma sample was collected properly (supine 30 minutes, fasting)
  • Consider whether acute illness or stress was present during testing
  • Only if borderline biochemical results persist with strong clinical suspicion should clonidine suppression testing be considered 1—but this is not indicated here given completely normal plasma metanephrines

Alternative Diagnoses to Consider:

Given normal TSH, CBC, and CMP, explore other causes of the patient's presenting symptoms (which you haven't specified but presumably prompted this workup):

  • Essential hypertension
  • Anxiety disorders
  • Medication effects
  • Other endocrine disorders (though pheochromocytoma is excluded)

The bottom line: Normal plasma free metanephrines measured by appropriate methodology effectively rule out pheochromocytoma, regardless of other test results 3, 2, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.